The new status gives MKRH its own Board of Directors, an approved organizational structure, and direct funding from the National Exchequer.
Under the partnership, the two organizations will work together to enhance HMC’s Clinical Trials Unit (CTU), strengthen research expertise, and develop initiatives that support the continued growth of Qatar’s healthcare sector.
The newly formed organization brings together four established healthcare brands including Aster DM, CARE Hospitals, Evercare and KIMSHEALTH, under a single platform focused on expanding access to advanced and affordable medical care across the country.
Researchers found that postmenopausal women taking hormone therapy while receiving tirzepatide lost approximately 35% more weight than women treated with tirzepatide alone.
For patients, the recognition reflects a healthcare environment where nurses receive strong institutional support to deliver safe, compassionate, and patient-centred care.
The centre will treat patients with a broad range of conditions, including stroke, spinal cord injuries, traumatic brain injuries, multiple sclerosis, cerebral palsy, autism spectrum disorder, muscular dystrophy, motor neuron disease, movement disorders, Alzheimer’s disease, dementia, ataxia, and dystonia.
Alzheimer’s disease affects more than 55 million people worldwide, and that figure is projected to nearly triple by 2050.
The expanded facility will combine inpatient rehabilitation, outpatient specialty clinics, orthopaedic and musculoskeletal care, neurosciences, sports medicine, physical medicine, and cardiac rehabilitation within a single coordinated care model.
The initiative combines “Care for Her” by Aster Hospitals & Clinics and “Elle by Medcare,” a premium programme offered through Medcare hospitals and medical centres.
Surgeons completed the entire procedure through a 16 mm incision while the patient remained fully awake, eliminating the need for general anaesthesia.